How AI Is Optimizing the Detection and Management of Prostate Cancer Academic Article uri icon

abstract

  • Annually, approximately 20 million men are prostate-specific-antigen screened, and 1.3 million undergo an invasive biopsy to diagnose roughly 200,000 new cases, 50% of which end up being indolent. Approximately 30,000 men die of prostate cancer (PCa) yearly. Importantly, an estimated US$8 billion is spent on unnecessary biopsies. Thus, an integrative analysis and predictive model of prognosis is needed to help identify only lethal and aggressive forms of the disease.

author list (cited authors)

  • Yadav, K. K.

citation count

  • 3

publication date

  • September 2018